bpc-157 fda warning august 2025 Heal or Harm: Body Protective Compound-157 in the Gray Zone FDA's Overreach on Compounded Peptides
FDA's Overreach on Compounded Peptides On August 15 2025, the U.S. Food & Drug Administration (FDA) issued a Warning Letter to Platinum Biologics LLC for marketing umbilicalcordderived products including exosome products (NanoEx & Nano Xsomes) without approval. FDA moves toward easing restrictions on certain peptides BioPharma Dive BPC 157 Canada Research Guide 2026: Sourcing, and Compliance RFK Jr pushes for FDA approval of BPC 157 peptide Eric Topol, MD posted on the topic LinkedIn
Pay in 4 interest-free payments of $5.05 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 6 - Aug 11


